|Kenny Green||Edison Group, IR|
|Josh Phillipson||Director of Business Development and Investor Relations|
|Amir Reichman||Chief Executive Officer|
|Matthias Dobbelstein||Professor at University Medical Center, Gottingen|
Hi everyone. Good day. I would like to welcome all of you to BiondVax's Webinar. My name is Kenny Green from Edison Group and I'm part of the IR team at BiondVax. I would like to remind everyone that this conference call today is being recorded and the recording will be available later today on BiondVax's Investor Relations Web site.